The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial

Kent, 2011, The assessment of intelligibility in motor speech disorders, 21 Dorsey, 2018, Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the global burden of disease study 2016, Lancet Neurol, 17, 939, 10.1016/S1474-4422(18)30295-3 Logemann, 1978, Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients, J Speech Hear Disord, 43, 47, 10.1044/jshd.4301.47 Sapir, 2007, Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with individuals with idiopathic Parkinson disease: acoustic and perceptual findings, J Speech Lang Hear Res, 50, 899, 10.1044/1092-4388(2007/064) Miller, 2008, How do I sound to me? Perceived changes in communication in Parkinson's disease, Clin Rehabil, 22, 14, 10.1177/0269215507079096 Takahashi, 2016, Quality of life in people with Parkinson's disease: the relevance of social relationships and communication, J Phys Ther Sci, 28, 541, 10.1589/jpts.28.541 Duffy, 2019 Sapir, 2014, Multiple factors are involved in the dysarthria associated with Parkinson's disease: a review with implications for clinical practice and research, J Speech Lang Hear Res, 57, 1330, 10.1044/2014_JSLHR-S-13-0039 Kompoliti, 2000, Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s disease, Neurology, 54, 458, 10.1212/WNL.54.2.458 Baker, 1997, Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease, J Speech Lang Hear Res, 40, 615, 10.1044/jslhr.4003.615 Schulz, 2000, Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: a review of the literature, J Commun Disord, 33, 59, 10.1016/S0021-9924(99)00025-8 Pinto, 2004, Treatments for dysarthria in Parkinson's disease, Lancet Neurol, 3, 547, 10.1016/S1474-4422(04)00854-3 Tripoliti, 2008, Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation, Mov Disord, 23, 2377, 10.1002/mds.22296 Ramig, 2001, Intensive voice treatment (LSVT®) for patients with Parkinson's disease: a 2 year follow-up, J Neurol Neurosurg Psychiatry, 71, 493, 10.1136/jnnp.71.4.493 Ramig, 2001, Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls, Mov Disord, 16, 79, 10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H Ramig, 2018, Speech treatment in Parkinson's disease: randomized controlled trial (RCT), Mov Disord, 33, 1777, 10.1002/mds.27460 Kleim, 2008, Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage, J Speech Lang Hear Res, 51, 225, 10.1044/1092-4388(2008/018) Baumgartner, 2001, Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease, J Voice, 15, 105, 10.1016/S0892-1997(01)00010-8 Baumann, 2018, Neural correlates of hypokinetic dysarthria and mechanisms of effective voice treatment in Parkinson disease, Neurorehabil Neural Repair, 32, 1055, 10.1177/1545968318812726 Liotti, 2003, Hypophonia in Parkinson’s disease: neural correlates of voice treatment revealed by PET, Neurology, 60, 432, 10.1212/WNL.60.3.432 Narayana, 2010, Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance—Correlation analysis, Hum Brain Mapp, 31, 222 El Sharkawi, 2002, Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study, J Neurol Neurosurg Psychiatry, 72, 31, 10.1136/jnnp.72.1.31 Miles, 2017, Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: a pilot study, J Neurol Sci, 383, 180, 10.1016/j.jns.2017.11.015 Yorkston, 1988 Rosenbek, 1985, The dysarthrias: description, diagnosis and treatment, 97 Kim, 2011, An acoustic study of the relationships among neurologic disease, dysarthria type, and severity of dysarthria, J Speech Lang Hear Res, 54, 417, 10.1044/1092-4388(2010/10-0020) Hustad, 2006, Estimating the intelligibility of speakers with dysarthria, Folia Phoniatr Logop, 58, 217, 10.1159/000091735 Ramig, 1995, Comparison of two forms of intensive speech treatment for Parkinson disease, J Speech Hear Res, 38, 1232, 10.1044/jshr.3806.1232 Forrest, 1989, Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults, J Acoust Soc Am, 85, 2608, 10.1121/1.397755 Tjaden, 2014, Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis, J Speech Lang Hear Res, 57, 779, 10.1044/2014_JSLHR-S-12-0372 Dorsey, 2018, The Parkinson pandemic—A call to action, JAMA Neurol, 75, 9, 10.1001/jamaneurol.2017.3299 Boutron, 2008, Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration, Ann Intern Med, 148, 295, 10.7326/0003-4819-148-4-200802190-00008 Boutron, 2017, CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts, Ann Intern Med, 167, 40, 10.7326/M17-0046 Schwartz, 1997, The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials, Psychosom Med, 59, 362, 10.1097/00006842-199707000-00005 Rains, 2005, Behavioral research and the double-blind placebo-controlled methodology: challenges in applying biomedical standard to behavioral headache research, Headache, 45, 479, 10.1111/j.1526-4610.2005.05099.x Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Folstein, 1975, “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician, J Psychiat Res, 12, 189, 10.1016/0022-3956(75)90026-6 Beck, 1996 van der Kolk, 2019, Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial, Lancet Neurol, 18, 998, 10.1016/S1474-4422(19)30285-6 Švec, 2003, Measurement of vocal doses in speech: experimental procedure and signal processing, Logoped Phoniatr Vocol, 28, 181, 10.1080/14015430310018892 Tjaden, 2004, Rate and loudness manipulations in dysarthria: acoustic and perceptual findings, J Speech Lang Hear Res, 47, 766, 10.1044/1092-4388(2004/058) Yorkston, 1992, Intelligibility measurement as a tool in the clinical management of dysarthric speakers, 265 Borod, 2000, Neuropsychological assessment of emotional processing in brain-damaged patients, 80 Dumer, 2014, Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease, J Int Neuropsychol Soc, 20, 302, 10.1017/S1355617714000046 Dupuis, 2014, Intelligibility of emotional speech in younger and older adults, Ear Hear, 35, 695, 10.1097/AUD.0000000000000082 Beijer, 2012, Evaluating the suitability of orthographic transcription and intelligibility scale rating of semantically unpredictable sentences (SUS) for speech training efficacy research in dysarthric speakers with Parkinson's disease, J Med Speech-Lang Pathol, 20, 17 1989 Schafer, 2012, List equivalency of the AzBio sentence test in noise for listeners with normal-hearing sensitivity or cochlear implants, J Am Acad Audiol, 23, 501, 10.3766/jaaa.23.7.2 Boersma P, Weenink D. Praat: doing phonetics by computer (Version 6.0.21) [computer software]. 2017. Natick, 2015, MATLAB and statistics toolbox release (r2015b) [computer software], The MathWorks, Inc Duquesnoy, 1983, Effect of a single interfering noise or speech source upon the binaural sentence intelligibility of aged persons, J Acoust Soc Am, 74, 739, 10.1121/1.389859 Cannito, 2012, Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease, J Voice, 26, 214, 10.1016/j.jvoice.2011.08.014 Chang E, Chang Y. Word transcription VAS & sentence VAS (Version 1.0) [computer software] 2015. Contact authors for retrieval information. Muller, 1992, Power calculations for general linear multivariate models including repeated measures applications, J Am Stat Assoc, 87, 1209, 10.1080/01621459.1992.10476281 Stipancic, 2016, Comparison of intelligibility measures for adults with Parkinson's disease, adults with multiple sclerosis, and healthy controls, J Speech Lang Hear Res, 59, 230, 10.1044/2015_JSLHR-S-15-0271 Moya-Galé, 2019, Parkinson's disease-associated dysarthria: prevalence, impact and management strategies, Res Rev Parkinsonism, 9, 9, 10.2147/JPRLS.S168090 Abell, 2017, Group singing and health-related quality of life in Parkinson's disease, Health Psychol, 36, 55, 10.1037/hea0000412 Stegemöller, 2017, Effects of singing on voice, respiratory control and quality of life in persons with Parkinson's disease, Disabil Rehabil, 39, 594, 10.3109/09638288.2016.1152610 Tickle‐Degnen, 2010, Self‐management rehabilitation and health‐related quality of life in Parkinson's disease: a randomized controlled trial, Mov Disord, 25, 194, 10.1002/mds.22940 Trend, 2002, Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their carers, Clin Rehabil, 16, 717, 10.1191/0269215502cr545oa McClean, 2002, Association of orofacial with laryngeal and respiratory motor output during speech, Exp Brain Res, 146, 481, 10.1007/s00221-002-1187-5 McFarland, 2006, Clinical implications of cross-system interactions, Semin Speech Lang, 27, 300, 10.1055/s-2006-955119 Neel, 2009, Effects of loud and amplified speech on sentence and word intelligibility in Parkinson Disease, J Speech Lang Hear Res, 52, 1021, 10.1044/1092-4388(2008/08-0119) Morton, 2003, Effect of regression to the mean on decision making in health care, BMJ, 326, 1083, 10.1136/bmj.326.7398.1083 Moya-Galé, 2018, The effects of intensive speech treatment on conversational intelligibility in Spanish speakers with Parkinson's disease, Am J Speech Lang Pathol, 27, 154, 10.1044/2017_AJSLP-17-0032 LSVT Global. About Us. 2020. https://www.lsvtglobal.com/About_Us (accessed April 5, 2020). Theodoros, 2016, Clinical and quality of life outcomes of speech treatment for Parkinson's disease delivered to the home via telerehabilitation: a noninferiority randomized controlled trial, Am J Speech Lang Pathol, 25, 214, 10.1044/2015_AJSLP-15-0005 Nakayama, 2020, Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-speaking patients with Parkinson's disease, Rehabil Res Pract, 2020, 1 Martel-Sauvageau, 2015, Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease, Clin Linguist Phon, 29, 424, 10.3109/02699206.2015.1012301 Whitehill, 2011, Effect of LSVT on lexical tone in speakers with Parkinson's disease, Parkinsons Dis, 2011, 1, 10.4061/2011/897494 Sapir, 2003, Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study, Am J Speech Lang Pathol, 12, 387, 10.1044/1058-0360(2003/085) Fox, 2012, Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria, J Speech Lang Hear Res, 55, 930, 10.1044/1092-4388(2011/10-0235) Lu, 2013, Efficacy of intensive phonatory-respiratory treatment (LSVT) for presbyphonia: two case reports, J Voice, 27, e11